Dong Wenfang, Wang Xin, Wang Huan, You Jianjun, Zheng Ruobing, Xu Yihao, Zhang Xulong, Guo Junsheng, Ruan Jingjing, Fan Fei
The Twelfth Department of Plastic Surgery, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shijingshan, Beijing, China.
Department of Ear Reconstruction, Plastic Surgery Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Shijingshan, Beijing, China.
Facial Plast Surg Aesthet Med. 2022 Mar-Apr;24(2):102-108. doi: 10.1089/fpsam.2021.0264. Epub 2022 Feb 25.
To compare the effectiveness of an intercostal nerve block after costal cartilage harvest when a multimodal cocktail or ropivacaine plus patient-controlled analgesia is used, as measured by visual analog scale (VAS) scores, rescue analgesic consumption, and related complications. Eligible patients who underwent costal cartilage harvest were equally randomized to receive a multimodal cocktail (multimodal group) or ropivacaine plus patient-controlled analgesia (ropivacaine group). Of 112 patients assessed, 12 (10.7%) patients were excluded and 100 (89.3%) patients were enrolled and assigned to multimodal group ( = 50) and ropivacaine group ( = 50). The VAS scores in the multimodal group were significantly lower than those in the ropivacaine group both at rest (0.924 ± 0.073 vs. 1.920 ± 0.073, < 0.001) and during coughing (2.340 ± 0.083 vs. 3.944 ± 0.083, < 0.001) in mixed-effects model analysis. Rescue analgesic consumption and rate of complications were significantly lower in the multimodal group compared with the ropivacaine group (all < 0.05). Multimodal cocktail improved chest pain after costal cartilage harvest with less rescue analgesic consumption and complications compared with ropivacaine plus patient-controlled analgesia. ChiCTR2100042445.
为比较在肋软骨采集后使用多模式镇痛合剂或罗哌卡因加患者自控镇痛时肋间神经阻滞的有效性,通过视觉模拟量表(VAS)评分、补救性镇痛药物消耗量及相关并发症进行衡量。接受肋软骨采集的符合条件患者被随机分为两组,分别接受多模式镇痛合剂(多模式组)或罗哌卡因加患者自控镇痛(罗哌卡因组)。在评估的112例患者中,12例(10.7%)被排除,100例(89.3%)患者被纳入并分配至多模式组(n = 50)和罗哌卡因组(n = 50)。混合效应模型分析显示,多模式组在静息时(0.924±0.073 vs. 1.920±0.073,P < 0.001)和咳嗽时(2.340±0.083 vs. 3.944±0.083,P < 0.001)的VAS评分均显著低于罗哌卡因组。多模式组的补救性镇痛药物消耗量和并发症发生率均显著低于罗哌卡因组(均P < 0.05)。与罗哌卡因加患者自控镇痛相比,多模式镇痛合剂可改善肋软骨采集后的胸痛,且补救性镇痛药物消耗量和并发症更少。中国临床试验注册中心注册号:ChiCTR2100042445